Prospective cohort study of non-hospitalised COVID-19 patients: determining length of isolation and patient clinical development at home (COVID-HOME study)
- Funded by Netherlands Organisation for Health Research and Development (ZonMW)
- Total publications:0 publications
Grant number: 1.043E+13
Grant search
Key facts
Disease
COVID-19Start & end year
20202021Known Financial Commitments (USD)
$900,173.96Funder
Netherlands Organisation for Health Research and Development (ZonMW)Principal Investigator
PendingResearch Location
NetherlandsLead Research Institution
University Medical Center GroningenResearch Priority Alignment
N/A
Research Category
Epidemiological studies
Research Subcategory
Disease transmission dynamics
Special Interest Tags
N/A
Study Subject
Clinical
Clinical Trial Details
Not applicable
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
Project description The UMCG conducts research among COVID-19 patients who have not been admitted to a hospital and their family members. The researchers want to gain more insight into the impact and consequences of the disease on these patients and their families, in order to be able to use this information to make guidelines for the treatment of COVID-19 patients at home. Study Positively tested individuals are visited at home weekly to obtain clinical and laboratory data. This is done by, among other things, taking a nose / throat swab (cotton swab) and drawing blood. To see if the virus is spreading through other routes, urine, faeces and semen or vaginal swabs are also collected. Nose and throat swabs are also taken from family members of positively tested persons to determine whether and when they become infected. Importance The necessity and importance of this investigation is great in the current phase of relaxation of all measures and the possible new outbreaks that may result. The research is carried out in collaboration with the GGDs.